These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 2883177

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The neurochemical aspects of Alzheimer's disease].
    Almeida R, Gonçalves M.
    Acta Med Port; 1995 Oct; 8(10):567-72. PubMed ID: 8533618
    [Abstract] [Full Text] [Related]

  • 5. Applications of neuroreceptor imaging to psychiatry research.
    Smith GS, Koppel J, Goldberg S.
    Psychopharmacol Bull; 2003 Oct; 37(4):26-65. PubMed ID: 15131516
    [Abstract] [Full Text] [Related]

  • 6. Early stages of late onset Alzheimer's disease. Diagnostic criteria, protein metabolism, precursor loading effects, neurochemical and neuropsychological applications.
    Forssell LG, Hellström A, Ericsson K, Winblad B.
    Acta Neurol Scand Suppl; 1989 Oct; 121():1-95. PubMed ID: 2565644
    [No Abstract] [Full Text] [Related]

  • 7. Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease.
    Dickson TC, King CE, McCormack GH, Vickers JC.
    Exp Neurol; 1999 Mar; 156(1):100-10. PubMed ID: 10192781
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain.
    Korolainen MA, Goldsteins G, Nyman TA, Alafuzoff I, Koistinaho J, Pirttilä T.
    Neurobiol Aging; 2006 Jan; 27(1):42-53. PubMed ID: 16298240
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
    Pearce BR, Palmer AM, Bowen DM, Wilcock GK, Esiri MM, Davison AN.
    Neurochem Pathol; 2006 Jan; 2(4):221-32. PubMed ID: 6085697
    [Abstract] [Full Text] [Related]

  • 13. Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4.
    Tannenberg RK, Scott HL, Tannenberg AE, Dodd PR.
    Neurochem Int; 2006 Dec; 49(7):631-9. PubMed ID: 16814428
    [Abstract] [Full Text] [Related]

  • 14. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
    Van Dam D, Marescau B, Engelborghs S, Cremers T, Mulder J, Staufenbiel M, De Deyn PP.
    Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
    [Abstract] [Full Text] [Related]

  • 15. Some unanswered questions about the mechanisms and etiology of Alzheimer's disease.
    Terry RD.
    Dan Med Bull; 1985 Feb; 32 Suppl 1():22-4. PubMed ID: 2859147
    [No Abstract] [Full Text] [Related]

  • 16. Changes of neurocalcin, a calcium-binding protein, in the brain of patients with Alzheimer's disease.
    Shimohama S, Chachin M, Taniguchi T, Hidaka H, Kimura J.
    Brain Res; 1996 Apr 15; 716(1-2):233-6. PubMed ID: 8738246
    [Abstract] [Full Text] [Related]

  • 17. Neuropathologic changes in Alzheimer's disease.
    Wenk GL.
    J Clin Psychiatry; 2003 Apr 15; 64 Suppl 9():7-10. PubMed ID: 12934968
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Molecular pathology in Alzheimer's disease].
    Coria Balanzat F.
    Med Clin (Barc); 1988 May 07; 90(18):739-42. PubMed ID: 3172872
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.